Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has revived patent infringement litigation brought against Teva by dermatological company Galderma, a former subsidiary of Nestlé Skin Health. 30 January 2020
Big Pharma
DNA testing developer Natera is suing ArcherDX, a molecular technology company, for allegedly infringing a patent related to multiplex polymerase chain reaction technology. 29 January 2020
Americas
The US Federal Trade Commission and New York’s attorney general have sued incarcerated ‘pharma bro’ Martin Shkreli for allegedly monopolising the market for life-saving drug Daraprim. 28 January 2020
Big Pharma
Biopharmaceutical company AbbVie’s pending purchase of pharmaceutical company Allergan has moved a step closer, following the latter’s agreement to divest treatments brazikumab and Zenpep, in a development meant to satisfy antitrust regulations in the US. 28 January 2020
Biotechnology
Arnold & Porter partner Richard Dickinson has joined Bristows as a partner in its commercial and IP transactional practice in London. 28 January 2020
article
Parker Poe Adams & Bernstein has announced the addition of five patent attorneys to its life sciences team. 28 January 2020
Americas
Gilead Sciences has accused a US government agency of withholding information from the US Patent and Trademark Office when filing two patents for HIV pre-exposure prophylaxis. 27 January 2020
Big Pharma
Secondary medical use case trends and research exemptions are just two issues set to be discussed at C5’s 12th Pharma & Biotech Patent Litigation meeting, on February 25–26 in Amsterdam. 27 January 2020
Americas
Jason Markwell, a former partner at Belmore Neidrauer, has joined Fasken’s IP group in its Toronto office. 24 January 2020
Big Pharma
The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU. 24 January 2020